Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Chiesi Farmaceutici S.p.A. |
---|---|
Information provided by: | Chiesi Farmaceutici S.p.A. |
ClinicalTrials.gov Identifier: | NCT00382889 |
The aim of this study is to reveal that inhaled corticosteroid therapy combined with a short-acting beta2- agonist given on a symptom driven basis is as effective as traditional asthma therapy.
Thus, three advantages will be achieved:
Condition | Intervention | Phase |
---|---|---|
Asthma |
Drug: beclomethasone/salbutamol combination Drug: beclomethasone Drug: salbutamol |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Efficacy Study |
Official Title: | Multinational, Double Blind, Randomised, Parallel Group Study on the Therapeutic Efficacy and Safety of Beclomethasone Dipropionate 250 mg Combined With Salbutamol 100 mg in the Treatment of Patients With Mild Persistent Asthma. |
Estimated Enrollment: | 480 |
Study Start Date: | August 2002 |
Estimated Study Completion Date: | September 2004 |
Asthma is widely recognised as a chronic inflammatory disorder of the airways. The 1997 American National Heart Lung and Blood Institute (NHLBI) Guidelines states that a firm scientific basis exists to indicate that asthma results from complex interactions among inflammatory cells, mediators and the cells and tissues resident in the airways. Despite the existence of effective therapy people still die from asthma. It is pertinent to state that the clinical effect of a drug is not only dependent on the specific action of the drug, but also on the patient’s way of using it. Therefore, compliance is an important factor especially for chronic disorders such as asthma. Indeed, non compliance with asthma therapy is a serious problem. It has been reported that drug side effects, lifestyle, social and economic factors, method of drug delivery and dosing are factors that contribute to poor compliance. The consequences of poor compliance lead to increased morbidity due to increased symptoms and asthma exacerbation.
The NHLBI Guidelines recommend daily treatment for patients with mild persistent asthma with inhaled glucocorticoids (200-500mcg/die) and short-acting bronchodilators as needed but no more than 3-4 times a day. Comparisons: beclomethasone dipropionate 250 mg combined with salbutamol 100 mg “as needed”, vs salbutamol 100 mg alone “as needed”, vs beclomethasone 250 mg twice a day plus salbutamol 100 mg “as needed” and vs beclomethasone dipropionate 250 mg combined with salbutamol 100 mg twice a day plus salbutamol 100 mg “as needed”, in the treatment of patients with mild persistent asthma.
Ages Eligible for Study: | 18 Years to 65 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Austria | |
Pulmologisches Zentrum Der Stadt Wien | |
Wien, Austria | |
Ambulance for pediatrics and Pneumology | |
Wien, Austria | |
Italy | |
Dipartimento di scienze mediche oncologiche e radiologiche - sez. malattie apparato respiratorio | |
Modena, Italy | |
Nuove Cliniche Arcispedale S.Anna | |
Ferrara, Italy | |
Clinica Pneumologica padiglione Rasori - Univ. di Parma | |
Parma, Italy | |
DIMI - Dip. Medicina Interna - Univ. di Genova - clinica di malattie apparato respiratorio e allergologico | |
Genova, Italy | |
Univ. di Padova - Dipartimento di medicina ambientale e sanità pubblica | |
Padova, Italy | |
Dip. di Pneumologia - Osp. Tommaselli | |
Catania, Italy | |
Clinica di Malattie dell'Apparato Respiratorio dell'Univ. di Pavia - Policlinico S. Matteo | |
Pavia, Italy | |
Istituto di Fisiopatologia Respiratoria CNR - Ospedale Cervello | |
Palermo, Italy | |
Reparto Fisiologia Respiratoria - dip. Cardiotoracico - Ospedale Cisanello | |
Pisa, Italy | |
Poland | |
Clinic of Pneumology and Allergology | |
Lòdz, Poland | |
Clinic of Tubercolosis and Lung Diseases | |
Lòdz, Poland | |
Outpatient Clinic of Internal Diseases and Allergology | |
Bialystok, Poland | |
Clinic of Pneumology and Allergology of Medical Academy | |
Warszawa, Poland | |
Clinic of Pneumology - Institute of Internal Medicine of Medical Academy | |
Lódz, Poland | |
Specialist Group Medex | |
Bielsko Biala, Poland | |
Institute of Occupational Medicine - Clinic of Occupational Disesase | |
Lódz, Poland | |
Clinic of Pneumology and Allergology A.M. | |
Warszawa, Poland | |
Clinic of Infection Diseases and Allergology - Central Clinical Hospital of Military Medical Academy | |
Warszawa, Poland | |
Clinic of Internal Diseases Atopia Al. | |
Krakow, Poland | |
Pulmonologic Clinic - Poludnie os. Krakowiakòw | |
Krakow, Poland | |
Spain | |
Hospital Vall d'Hebron de Barcelona | |
Barcelona, Spain, 08035 | |
H.General de Vic, Servicio de Neumologia | |
Barcelona, Spain, 08500 | |
Hospital de Matarò | |
Mataro, Spain, 08304 |
Principal Investigator: | Leonardo M Fabbri, MD | Clinica di Malattie dell’Apparato Respiratorio, Dipartimento di Oncologia, Ematologia e Pneumologia, Università di Modena e Reggio Emilia, Italy |
Study ID Numbers: | MC/PR/1401/001/01 |
Study First Received: | September 29, 2006 |
Last Updated: | September 29, 2006 |
ClinicalTrials.gov Identifier: | NCT00382889 History of Changes |
Health Authority: | Italy: The Italian Medicines Agency; Poland: Ministry of Health; Spain: Ministry of Health and Consumption; Austria: Federal Ministry for Health and Women |
Anti-Asthmatic Agents corticosteroids symptom-driven beclomethasone salbutamol |
Anti-Inflammatory Agents Neurotransmitter Agents Adrenergic beta-Agonists Adrenergic Agents Bronchial Diseases Hormone Antagonists Albuterol Hormones, Hormone Substitutes, and Hormone Antagonists Asthma Beclomethasone Anti-Asthmatic Agents |
Hormones Glucocorticoids Adrenergic Agonists Lung Diseases, Obstructive Hypersensitivity Respiratory Tract Diseases Lung Diseases Hypersensitivity, Immediate Peripheral Nervous System Agents Bronchodilator Agents Respiratory Hypersensitivity |
Anti-Inflammatory Agents Respiratory System Agents Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action Bronchial Diseases Adrenergic Agents Albuterol Physiological Effects of Drugs Hormones, Hormone Substitutes, and Hormone Antagonists Beclomethasone Reproductive Control Agents Hormones Adrenergic Agonists Hypersensitivity Lung Diseases, Obstructive |
Respiratory Tract Diseases Tocolytic Agents Therapeutic Uses Immune System Diseases Adrenergic beta-Agonists Asthma Anti-Asthmatic Agents Glucocorticoids Pharmacologic Actions Autonomic Agents Lung Diseases Hypersensitivity, Immediate Peripheral Nervous System Agents Bronchodilator Agents Respiratory Hypersensitivity |